Dosidal · Switzerland

Azelastin Fluticason Sandoz Nasenspray, Suspension

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:69878 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 69878
atc: R01AD58
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2025-11-20
term: zugelassen
valid_until: 2030-11-19
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: R01AD58
authorisation_number: 69878
form: NASSS
holder: Sandoz Pharmaceuticals AG
holder_partner_nr: 1006431
it_number: 12.02.2.
name: Azelastin Fluticason Sandoz Nasenspray, Suspension
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
hIwKC3KqW5Ee7LL-bkbB6Kh9H2V9Zo6cfDw-0YWlkBrkX-o1ascFRhheu2JWonjkI7yyktZ6kuaFSUWMy8No0Q
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:69878 · Related records in other markets · Dosidal